Literature DB >> 10326295

Drug resistance in malaria.

N J White1.   

Abstract

Drug resistance in malaria is now widespread and in many parts of the world is making treatment increasingly difficult. This article reviews current knowledge of the mechanisms and extent of resistance of Plasmodium falciparum and P. vivax to the available antimalarial drugs, and the recommendations for treating malaria in regions where resistance is prevalent.

Entities:  

Mesh：

Substances：

Year:  1998        PMID： 10326295     DOI： 10.1093/oxfordjournals.bmb.a011721

Source DB:  PubMed          Journal:  Br Med Bull        ISSN： 0007-1420            Impact factor:   4.291


  34 in total

1.  Comparison of efficacies of cysteine protease inhibitors against five strains of Plasmodium falciparum.

Authors:  A Singh; P J Rosenthal
Journal:  Antimicrob Agents Chemother       Date:  2001-03       Impact factor: 5.191

Review 2.  Sulfadoxine-pyrimethamine plus artesunate versus sulfadoxine-pyrimethamine plus amodiaquine for treating uncomplicated malaria.

Authors:  H Bukirwa; J Critchley
Journal:  Cochrane Database Syst Rev       Date:  2006-01-25

Review 3.  Drug resistance and genetic mapping in Plasmodium falciparum.

Authors:  Karen Hayton; Xin-Zhuan Su
Journal:  Curr Genet       Date:  2008-09-18       Impact factor: 3.886

4.  Antimalarial activities of new pyrrolo[3,2-f]quinazoline-1,3-diamine derivatives.

Authors:  Jian Guan; Quan Zhang; Michael O'Neil; Nicanor Obaldia; Arba Ager; Lucia Gerena; Ai J Lin
Journal:  Antimicrob Agents Chemother       Date:  2005-12       Impact factor: 5.191

5.  A plastid segregation defect in the protozoan parasite Toxoplasma gondii.

Authors:  C Y He; M K Shaw; C H Pletcher; B Striepen; L G Tilney; D S Roos
Journal:  EMBO J       Date:  2001-02-01       Impact factor: 11.598

6.  Identification of novel phenyl butenonyl C-glycosides with ureidyl and sulfonamidyl moieties as antimalarial agents.

Authors:  K Kumar G Ramakrishna; Sarika Gunjan; Akhilesh Kumar Shukla; Venkata Reddy Pasam; Vishal M Balaramnavar; Abhisheak Sharma; Swati Jaiswal; Jawahar Lal; Renu Tripathi; Ravishankar Ramachandran; Rama Pati Tripathi
Journal:  ACS Med Chem Lett       Date:  2014-06-02       Impact factor: 4.345

7.  Antimalarial evaluation of copper(II) nanohybrid solids: inhibition of plasmepsin II, a hemoglobin-degrading malarial aspartic protease from Plasmodium falciparum.

Authors:  Subash Chandra Mohapatra; Hemandra Kumar Tiwari; Manisha Singla; Brijesh Rathi; Arun Sharma; Kuldeep Mahiya; Mukesh Kumar; Saket Sinha; Shyam Singh Chauhan
Journal:  J Biol Inorg Chem       Date:  2009-11-28       Impact factor: 3.358

Review 8.  Global change and human vulnerability to vector-borne diseases.

Authors:  Robert W Sutherst
Journal:  Clin Microbiol Rev       Date:  2004-01       Impact factor: 26.132

9.  Comparative transcriptional and genomic analysis of Plasmodium falciparum field isolates.

Authors:  Margaret J Mackinnon; Jinguang Li; Sachel Mok; Moses M Kortok; Kevin Marsh; Peter R Preiser; Zbynek Bozdech
Journal:  PLoS Pathog       Date:  2009-10-30       Impact factor: 6.823

10.  In vitro selection of RNA aptamers against a conserved region of the Plasmodium falciparum erythrocyte membrane protein 1.

Authors:  Anders Barfod; Tina Persson; Johan Lindh
Journal:  Parasitol Res       Date:  2009-08-20       Impact factor: 2.289
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.